The ** Conference on Trends and Technologies of Improved New Drugs in Westin Hotel of the Liberation Stone Tablet in Chongqing on June 17-18, 2021
In the conference, it was pointed out that pharmaceutical innovation is an important way for Chinese new drugs to move from Chinese to global . Especially under the premise of increasingly high threshold of innovative drugs and increasingly fierce competition, traditional pharmaceutical enterprises, which previously enjoyed the “protection” from policies and Chinese-style market relations, will be swallowed up by the trend if they remain unchanged, but will face the problems of long new drug development cycle, high investment and high risk if they change.
Exhibition site:
There is a high technical threshold for pharmaceutical innovation, and it is still stuck in the contradiction between good prospects and poor status, which also indicates future investment opportunities in the field of pharmaceutical innovation. Therefore, the major challenge for China’s pharmaceutical enterprises is to strengthen the core competitiveness of enterprises and determine the R&D strategy along with the innovation path.
Nanocoulter I, based on the classical Coulter Principle, carried high-end biochips and established an internationally advanced nanoparticle analysis platform, which can accurately measure the concentration, particle size, zeta potential and morphology of nanoparticles. Single particle detection of nanoparticles and liquid biopsy of biological samples can further realize single molecular immunodetection and promote the development of pharmaceutical innovation technology.
Outstanding features:
Accurate single particle measurement is implemented for the concentration, particle size, zeta potential of nanoparticles.
Application field:
Detection of concentration, particle size and zeta potential of liposomes, proteins, viruses and viruslike particles. Dynamics process description of particle agglomeration, polymerization and fracture.
Identification of extracellular vesicles and exosomes. Result analysis of isolation and purification of exosomes. Comparison of differences between different isolation and purification methods.
Determination of particle size and concentration of drug carrier, vaccine and artificial chyle particles, control of production differences between batches.
Count of particles such as blood cells, platelets, bacteria and immunodetection function particles.
Quality control of inorganic particles such as colloidal gold, colloidal silver, polystyrene microspheres and magnetic bead particles.
Research on properties of industrial production materials such as cosmetics, semiconductors, industrial coatings, dyes and ink chemistry, mechanical polishing and catalysts, etc.
